These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 19620510

  • 1. Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure.
    Wilson RM, De Silva DS, Sato K, Izumiya Y, Sam F.
    Hypertension; 2009 Sep; 54(3):583-90. PubMed ID: 19620510
    [Abstract] [Full Text] [Related]

  • 2. Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
    Sam F, Duhaney TA, Sato K, Wilson RM, Ohashi K, Sono-Romanelli S, Higuchi A, De Silva DS, Qin F, Walsh K, Ouchi N.
    Endocrinology; 2010 Jan; 151(1):322-31. PubMed ID: 19850745
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
    Zamani P, Akers S, Soto-Calderon H, Beraun M, Koppula MR, Varakantam S, Rawat D, Shiva-Kumar P, Haines PG, Chittams J, Townsend RR, Witschey WR, Segers P, Chirinos JA.
    J Am Heart Assoc; 2017 Feb 20; 6(2):. PubMed ID: 28219917
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH.
    N Engl J Med; 1986 Jun 12; 314(24):1547-52. PubMed ID: 3520315
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction.
    Nyolczas N, Dékány M, Muk B, Szabó B.
    Adv Exp Med Biol; 2018 Jun 12; 1067():31-45. PubMed ID: 29086392
    [Abstract] [Full Text] [Related]

  • 10. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH.
    Dan Med Bull; 2001 Nov 12; 48(4):199-210. PubMed ID: 11767125
    [Abstract] [Full Text] [Related]

  • 11. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT).
    Carson P, Johnson G, Fletcher R, Cohn J.
    J Am Coll Cardiol; 1996 Mar 01; 27(3):642-9. PubMed ID: 8606276
    [Abstract] [Full Text] [Related]

  • 12. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
    Mantle JA, Russell RO, Moraski RE, Rackley CE.
    Am J Cardiol; 1976 Feb 01; 37(2):263-8. PubMed ID: 1108634
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
    Massie BM, Kramer B, Shen E, Haughom F.
    Br Heart J; 1981 Apr 01; 45(4):376-84. PubMed ID: 7225252
    [Abstract] [Full Text] [Related]

  • 15. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
    Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M.
    N Engl J Med; 1991 Aug 01; 325(5):303-10. PubMed ID: 2057035
    [Abstract] [Full Text] [Related]

  • 16. Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis rats.
    Jessup JA, Lindsey SH, Wang H, Chappell MC, Groban L.
    PLoS One; 2010 Nov 03; 5(11):e15433. PubMed ID: 21082029
    [Abstract] [Full Text] [Related]

  • 17. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K.
    Am J Cardiovasc Drugs; 2002 Nov 03; 2(1):1-6. PubMed ID: 14727993
    [Abstract] [Full Text] [Related]

  • 18. A randomised study of the haemodynamic changes induced by venodilatation and arteriolar dilatation singly and together in left ventricular failure complicating acute myocardial infarction.
    Nelson GI, Verma SP, Hussain M, Silke B, Forsyth D, Abdulali S, Taylor SH.
    J Cardiovasc Pharmacol; 1984 Nov 03; 6(2):331-8. PubMed ID: 6200724
    [Abstract] [Full Text] [Related]

  • 19. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Endemann DH, Touyz RM, Iglarz M, Savoia C, Schiffrin EL.
    Hypertension; 2004 Jun 03; 43(6):1252-7. PubMed ID: 15117913
    [Abstract] [Full Text] [Related]

  • 20. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M, Machida N, Mitsuishi M, Yamane Y.
    Am J Hypertens; 2004 Dec 03; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.